首页> 外国专利> Analysis of new anthrax to replace single-ring and bicycle ring systems as PRMT5 inhibitors

Analysis of new anthrax to replace single-ring and bicycle ring systems as PRMT5 inhibitors

机译:分析新炭疽替代PRMT5抑制剂的单环和自行车环系统

摘要

1. A formula compound (I) or a salt with acceptable efficacy, wherein R1 and R2 are H-C (= O) (-) (C1-4 tar);This is - ch2-o-cf2Z is -CH2.-C? Page: 1Among other things, AR is a monocyclic aromatic ring, such as pyridine, pyridinediol or bicycle ring system; het is a heterocyclic aromatic bicycle ring system selected from (A-1),(A-2) and (A-3);R3a, R3d and R3e are H, halo, among others; R4a, R4d, R4e, R4f and R4g are H, C1-4 alkyl, among others; Q1 is N or CR6a; Q2 is N or CR6b; Q8 is N or CR6g; Q9 is N or CR6h; Q10 is N or CR6i; Q11 is N or CR6j; R6a, R6b, R6h, R6i and R6j are H, halo, among others; Q5 is N or CR3d, Q6 is N or CR4e; Q7 is N or CR4f. It also refers to pharmaceutical compositions comprising the compound of the invention and methods of preparation. These compounds are inhibitors of the protein arginine methyltransferase 5 (PRMT5) and are useful in the treatment of diseases such as cancer.
机译:1.一种通式(I)的化合物或其盐,其中R 1和R 2为H-C(= O)(-)(C1-4焦油); -CH2-O-CF2Z为-CH2-。 Page:1在其他事物中,AR是单环芳族环,例如吡啶,吡啶二醇或自行车环系统; het是选自(A-1),(A-2)和(A-3)的杂环芳香族自行车环系统; R 3a,R 3d和R 3e是H,卤素等。 R 4a,R 4d,R 4e,R 4f和R 4g是H,C 1-4烷基等。 Q1为N或CR6a; Q2为N或CR6b; Q8为N或CR6g; Q9为N或CR6h; Q10是N或CR6i; Q11是N或CR6j; R 6a,R 6b,R 6h,R 6i和R 6j是H,卤素等。 Q5为N或CR3d,Q6为N或CR4e; Q7是N或CR4f。还涉及包含本发明化合物的药物组合物及其制备方法。这些化合物是精氨酸甲基转移酶5(PRMT5)的抑制剂,可用于治疗疾病,例如癌症。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号